Search results
Results from the WOW.Com Content Network
Psilocybin, the active chemical ingredient in psychedelic mushrooms, may be beneficial in the treatment of episodic migraines, suggests a review published earlier this month.
Psychedelic treatments for trauma-related disorders are the use of psychedelic substances, either alone or used in conjunction with psychotherapy, to treat trauma-related disorders. [1] Trauma-related disorders, such as post-traumatic stress disorder (PTSD), have a lifetime prevalence of around 8% in the US population. [ 2 ]
Psilocybin-containing mushrooms. Psilocybin therapy is the use of psilocybin (the psychoactive ingredient in psilocybin mushrooms) in treating a range of mental health conditions, such as depression, anxiety, addictions, [1] obsessive compulsive disorder (OCD), and psychosis. [2] It is one of several forms of psychedelic therapy under study.
The first article to bring attention to the uses of psychedelic drugs for mental health was titled, "Seeking the Magic Mushroom", written by Robert Gordon Wasson and published in 1957 by TIME magazine. It detailed his experience traveling to Oaxaca, Mexico and taking "magic mushrooms" (psilocybin) within the cultural practices that started the ...
Crab-Stuffed Mushrooms. In the world of fancy bite-size appetizers, the crab-stuffed mushroom reigns supreme. These are also great with chopped, cooked lobster or shrimp meat, but try to avoid ...
However, fatal events related to emotional distress and trip-induced psychosis can occur as a result of over-consumption of psilocybin mushrooms. In 2003, a 27-year-old man was found dead in an irrigation canal due to hypothermia. In his bedroom was found two cultivation pots of psilocybin mushrooms, but no report of toxicology was made. [50]
Psychedelic therapy (or psychedelic-assisted therapy) is the proposed use of psychedelic drugs to treat mental disorders. [59] As of 2021, psychedelic drugs are controlled substances in most countries and psychedelic therapy is not legally available outside clinical trials, with some exceptions.
A slowly increasing number of employers—mostly those who’ve experienced the benefits themselves—are giving their employees access to psychedelic-assisted psychotherapy as part of their ...